Mepolizumab alters the phenotype and activation status of peripheral blood eosinophils in patients with severe eosinophilic asthma - Milan 2023

Innovative approaches to managing asthma and chronic obstructive pulmonary disease: a translational perspective

Chair(s): Lena Uller, Manali Mukherjee

Session type: Oral presentation

Mepolizumab alters the phenotype and activation status of peripheral blood eosinophils in patients with severe eosinophilic asthma

Pablo Miguens-Suarez

EVENTS HOME

Previous presentation

Next presentation

Session content

Late Breaking Abstract - Early improvement in asthma small airway dysfunction after one dose of SAR443765, a novel bispecific anti-thymic stromal lymphopoietin/anti-IL-13 nanobody molecule

Annemie Deiteren

Replay

Poster

Abstract

Slides

Autologous transplantation of P63+ lung progenitor cells for chronic obstructive pulmonary disease therapy

Wei Zuo

Replay

Abstract

Slides

Relationship between IL-33 expression and epithelial remodelling in COPD small airways

Sophie Booth

Replay

Poster

Abstract

Slides

A novel senotherapeutic approach for COPD via activating autophagy-lysosome axis

Sachi Matsubayashi

Replay

Poster

Abstract

Slides

SIL-6R? amplified IL-6 signaling in bronchial epithelial cells defines a subgroup of asthma patients low in sputum eosinophils

Reinoud Gosens

Replay

Poster

Abstract

Slides

Mepolizumab alters the phenotype and activation status of peripheral blood eosinophils in patients with severe eosinophilic asthma

Pablo Miguens-suarez

Replay

Poster

Abstract

Slides

Effect of add-on therapies (mepolizumab, omalizumab or azithromycin) on asthma remission in severe asthma

Dennis Thomas

Replay

Poster

Abstract

Slides

Effect of in vitro azithromycin treatment on epithelial antiviral immunity in eosinophilic and non-eosinophilic asthma phenotypes

Muzhda Ghanizada

Replay

Poster

Abstract

Slides

NK cell maturation and proliferation in severe asthmatic patients after Benralizumab therapy

Laura Bergantini

Replay

Poster

Abstract

Slides

The inhaled PDE4 inhibitor tanimilast shows efficacy in both Th2 and non-Th2 murine models of asthma

Anna Rita Pisano

Replay

Poster

Abstract

Slides

Discussion and Q&A

Replay

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}